Susquehanna Fundamental Investments’s Dr. Reddy's Laboratories RDY Stock Holding History

Susquehanna Fundamental Investments’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-32,410	Closed	-$422K	–	1714
2021 Q3	$422K	Sell	32,410 -37,840	-54%	-$504K	0.01%	1277
2021 Q2	$1.03M	Buy	70,250 +7,250	+12%	+$101K	0.02%	847
2021 Q1	$774K	Sell	63,000 -63,055	-50%	-$810K	0.01%	988
2020 Q4	$1.8M	Buy	126,055 +20,045	+19%	+$270K	0.03%	658
2020 Q3	$1.48M	Buy	+106,010	New	+$1.26M	0.04%	524

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Susquehanna Fundamental Investments's RDY Position: Q4 2021 in Review

Susquehanna Fundamental Investments sold out of Dr. Reddy's Laboratories (RDY) in Q4 2021, closing a stake of 32,410 shares — an estimated $422K sold.

Susquehanna Fundamental Investments first reported a position in RDY in Q3 2020 and held it in 5 quarters. The position peaked at $1.8M in Q4 2020. 148 funds tracked by Wall St. Rank hold RDY as of Q4 2021.

Susquehanna Fundamental Investments reported no remaining Dr. Reddy's Laboratories position as of Q4 2021 after selling out during the quarter.
Susquehanna Fundamental Investments sold 32,410 Dr. Reddy's Laboratories shares in Q4 2021, an estimated $422K.
Susquehanna Fundamental Investments first reported a position in Dr. Reddy's Laboratories in Q3 2020 and held it in 5 quarters.
Susquehanna Fundamental Investments's Dr. Reddy's Laboratories position peaked at $1.8M in Q4 2020.
148 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2021, filed 14 Feb 2022.